id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
aiua-8854	Frantellizzi, Viviana; Lazri, Julia; Pontico, Mariano; Pani, Arianna; De Vincentis, Giuseppe	Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC	2020	4	.pdf	application/pdf	3190	184	52	Radium-223 is a tar- geted alpha-therapy approved for the treatment of mCRPC (metastatic castration resistant prostate cancer) patients with symptomatic bone metastases. Taking into account the effectiveness on bone pain relief and the low toxicity profile showed by Radium-223 treatment, we encourage further analysis on large cohort to investigate the clinical outcome after Radium-223 treatment, in terms of bone pain palliation, together with the possibility of Radium-223 re-treatment in selected patients.. KEY WORDS: Radium-223 dichloride; Bone pain; Palliative treatment; mCRPC.	cache/aiua-8854.pdf	txt/aiua-8854.txt